Related Experiment Videos
Small joint involvement: systematic roentgenographic study in rheumatoid arthritis
Annals of the Rheumatic Diseases
|April 1, 1987
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Is There a Renaissance of Glucocorticoids in Rheumatoid Arthritis?
Clinical pharmacology and therapeutics·2017
Dual islet transplantation modeling of the instant blood-mediated inflammatory reaction.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases.
Annals of the rheumatic diseases·2013
Belatacept and sirolimus prolong nonhuman primate islet allograft survival: adverse consequences of concomitant alefacept therapy.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2013
Our approach to the diagnosis and treatment of polymyalgia rheumatica and giant cell (temporal) arteritis.
The journal of the Royal College of Physicians of Edinburgh·2012
Nondepleting anti-CD40-based therapy prolongs allograft survival in nonhuman primates.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2011
A global OMERACT ultrasound joint damage scoring system (GLODS) in rheumatoid arthritis.
Annals of the rheumatic diseases·2026
Circulating biomarkers in patients with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial.
Annals of the rheumatic diseases·2026
Clinical outcomes of upadacitinib continuation vs withdrawal in giant cell arteritis through 2 years.
Annals of the rheumatic diseases·2026
Spatial transcriptomics reveals mechanism of autoimmunity driven by internalised autoantibodies.
Annals of the rheumatic diseases·2026
A phase 2 trial of rilzabrutinib in IgG4-related disease.
Annals of the rheumatic diseases·2026